Quest Diagnostics Incorporated
DGX
$190.18
$0.370.20%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 2.90B | 2.81B | 2.82B | 2.76B | 2.65B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.90B | 2.81B | 2.82B | 2.76B | 2.65B |
| Cost of Revenue | 1.95B | 1.89B | 1.87B | 1.82B | 1.78B |
| Gross Profit | 944.00M | 915.00M | 951.00M | 944.00M | 869.00M |
| SG&A Expenses | 498.00M | 486.00M | 491.00M | 480.00M | 463.00M |
| Depreciation & Amortization | 37.00M | 37.00M | 39.00M | 39.00M | 39.00M |
| Other Operating Expenses | -2.00M | 0.00 | 1.00M | 2.00M | -- |
| Total Operating Expenses | 2.48B | 2.41B | 2.40B | 2.34B | 2.29B |
| Operating Income | 411.00M | 392.00M | 420.00M | 423.00M | 367.00M |
| Income Before Tax | 338.00M | 337.00M | 336.00M | 393.00M | 294.00M |
| Income Tax Expenses | 74.00M | 81.00M | 77.00M | 97.00M | 59.00M |
| Earnings from Continuing Operations | 264.00M | 256.00M | 259.00M | 296.00M | 235.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -12.00M | -11.00M | -14.00M | -14.00M | -15.00M |
| Net Income | 252.00M | 245.00M | 245.00M | 282.00M | 220.00M |
| EBIT | 411.00M | 392.00M | 420.00M | 423.00M | 367.00M |
| EBITDA | 558.00M | 537.00M | 562.00M | 566.00M | 507.00M |
| EPS Basic | 2.28 | 2.21 | 2.17 | 2.51 | 1.97 |
| Normalized Basic EPS | 1.88 | 1.84 | 1.94 | 1.98 | 1.64 |
| EPS Diluted | 2.24 | 2.20 | 2.16 | 2.47 | 1.94 |
| Normalized Diluted EPS | 1.85 | 1.82 | 1.92 | 1.97 | 1.61 |
| Average Basic Shares Outstanding | 110.00M | 111.00M | 112.00M | 112.00M | 111.00M |
| Average Diluted Shares Outstanding | 112.00M | 112.00M | 113.00M | 113.00M | 113.00M |
| Dividend Per Share | 0.86 | 0.80 | 0.80 | 0.80 | 0.80 |
| Payout Ratio | 34.92% | 36.73% | 36.33% | 31.91% | 38.18% |